0001104659-21-069940.txt : 20210520 0001104659-21-069940.hdr.sgml : 20210520 20210520163651 ACCESSION NUMBER: 0001104659-21-069940 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210518 FILED AS OF DATE: 20210520 DATE AS OF CHANGE: 20210520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JACOB GARY S CENTRAL INDEX KEY: 0001266802 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36856 FILM NUMBER: 21944992 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 FORMER COMPANY: FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130806 4 1 tm2117144d6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-05-18 0 0001583771 Hepion Pharmaceuticals, Inc. HEPA 0001266802 JACOB GARY S C/O HEPION PHARMACEUTICALS, INC. 399 THORNALL STREET, FIRST FLOOR EDISON NJ 08837 1 0 0 0 Stock Options 1.70 2021-05-18 4 A 0 250000 0 A 2022-05-18 2031-05-18 Common Stock 250000 342785 D Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan. /s/ Gary Jacob 2021-05-20